Mechanisms of β-Cell Death in Type 2 Diabetes
- Marc Y. Donath1,
- Jan A. Ehses1,
- Kathrin Maedler1,
- Desiree M. Schumann1,
- Helga Ellingsgaard1,
- Elisabeth Eppler2 and
- Manfred Reinecke2
- 1Division of Endocrinology and Diabetes, University Hospital Zurich, Zurich, Switzerland
- 2Division of Neuroendocrinology, Institute of Anatomy, University of Zurich, Zurich, Switzerland
- Address correspondence and reprint requests to Marc Y. Donath, MD, Division of Endocrinology and Diabetes, Department of Medicine, University Hospital, CH-8091 Zurich, Switzerland. E-mail: marc.donath{at}usz.ch
Abstract
A decrease in the number of functional insulin-producing β-cells contributes to the pathophysiology of type 2 diabetes. Opinions diverge regarding the relative contribution of a decrease in β-cell mass versus an intrinsic defect in the secretory machinery. Here we review the evidence that glucose, dyslipidemia, cytokines, leptin, autoimmunity, and some sulfonylureas may contribute to the maladaptation of β-cells. With respect to these causal factors, we focus on Fas, the ATP-sensitive K+ channel, insulin receptor substrate 2, oxidative stress, nuclear factor-κB, endoplasmic reticulum stress, and mitochondrial dysfunction as their respective mechanisms of action. Interestingly, most of these factors are involved in inflammatory processes in addition to playing a role in both the regulation of β-cell secretory function and cell turnover. Thus, the mechanisms regulating β-cell proliferation, apoptosis, and function are inseparable processes.
- ER, endoplasmic reticulum
- FLIP, FLICE inhibitory protein
- IL, interleukin
- KATP channel, ATP-sensitive K+ channel
- NF, nuclear factor
Footnotes
-
This article is based on a presentation at a symposium. The symposium and the publication of this article were made possible by an unrestricted educational grant from Servier.
-
- Accepted May 5, 2005.
- Received March 2, 2005.
- DIABETES











